ABELMOSCHUS (HOMEOLAB USA INC)


Welcome to the PulseAid listing for the ABELMOSCHUS drug offered from HOMEOLAB USA INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC
NON-PROPRIETARY NAME: ABELMOSCHUS
SUBSTANCE NAME: ABELMOSCHUS MOSCHATUS SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2013-11-14
END MARKETING DATE: 0000-00-00


ABELMOSCHUS HUMAN OTC DRUG Details:

Item DescriptionABELMOSCHUS from HOMEOLAB USA INC
LABELER NAME: HOMEOLAB USA INC
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/1)
START MARKETING DATE: 2013-11-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6435_45084b0d-210b-4fc5-afa7-2f83fb28924e
PRODUCT NDC: 60512-6435
APPLICATION NUMBER:

Other ABELMOSCHUS MOSCHATUS SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INCABELMOSCHUS
Washington Homeopathic ProductsAbelmoschus